Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages
I. Kustiawan
Blood, 2014
View PDFchevron_right
Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells
Alan Lazarus
Nature Medicine, 2006
View PDFchevron_right
The Role of the Human Fc Receptor FcγRIIA in the Immune Clearance of Platelets: A Transgenic Mouse Model
Saul Surrey
The Journal of Immunology, 1999
View PDFchevron_right
Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcγRI), blocks phagocytosis, and modulates receptor expression
Paul Guyre
Journal of Leukocyte Biology, 1997
View PDFchevron_right
Intravenous immunoglobulin and immune response
Chaitrali Saha
Clinical and experimental immunology, 2014
View PDFchevron_right
Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia
Wim Bleeker
Blood, 2001
View PDFchevron_right
The role of Fcγ receptors in murine autoimmune thrombocytopenia
Anja Lux, Markus Biburger, Falk Nimmerjahn
Annals of Hematology, 2010
View PDFchevron_right
Low-affinity FcγR interactions can decide the fate of novel human IgG-sensitised red blood cells and platelets
Mike Clark
European Journal of Immunology, 2014
View PDFchevron_right
Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcγRII and FcγRIIIb
Wim Bleeker
The Journal of …, 2004
View PDFchevron_right
Interaction of intravenous immunoglobulines (IVIG) with Fcgamma-receptors: activation and inhibition of phagocyte functions
J. Teeling
2001
View PDFchevron_right
Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders
Paul A . Imbach
Vox sanguinis, 2010
View PDFchevron_right
Modulation of the cellular immune system by intravenous immunoglobulin
Srinivas KAVERI
Trends in Immunology, 2008
View PDFchevron_right
FcγRI blockade and modulation for immunotherapy
Paul Guyre
Cancer Immunology, Immunotherapy, 1997
View PDFchevron_right
Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ib and Fc RIIa in immune thrombocytopenia
Hans Deckmyn
Haematologica, 2013
View PDFchevron_right
Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG
Alan Lazarus
Blood, 2003
View PDFchevron_right
Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator’s report
Peter Ligthart
Transfusion Clinique et Biologique, 2002
View PDFchevron_right
Mechanisms of action of intravenous immune globulin in immune-mediated diseases
Sergio Spalter
Clinical and Experimental Immunology, 1996
View PDFchevron_right
Intravenous immunoglobulin products: an update on their mechanisms of action
Alan Lazarus
ISBT Science Series, 2008
View PDFchevron_right
Inflammation in autoimmunity: receptors for IgG revisited
Cees Kallenberg
Trends in Immunology, 2001
View PDFchevron_right
Differential Contribution of Three Activating IgG Fc Receptors (Fc RI, Fc RIII, and Fc RIV) to IgG2a- and IgG2b-Induced Autoimmune Hemolytic Anemia in Mice
Falk Nimmerjahn
The Journal of Immunology, 2008
View PDFchevron_right
Platelet FcγRIIA binds and internalizes IgG-containing complexes
Randall Worth
Experimental Hematology, 2006
View PDFchevron_right
Intravenous immunoglobulins – understanding properties and mechanisms
Milan Basta
Clinical and Experimental Immunology, 2009
View PDFchevron_right
Increased Phagocyte FcgRI Expression and Improved Fcg-Receptor - Mediated Phagocytosis After In Vivo Recombinant Human Interferon-g Treatment of Normal Human Subjects
Deborah Schiff
1997
View PDFchevron_right
Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody
Lubna Abuqayyas
International Journal of Pharmaceutics, 2013
View PDFchevron_right
Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells
Isabelle St-amour
British Journal of Haematology, 2004
View PDFchevron_right
ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis
Jacob Pendergrast
Blood, 2018
View PDFchevron_right
The Binding of Human IgG to Minipig FcγRs – Implications for Preclinical Assessment of Therapeutic Antibodies
Tilman Schlothauer
Pharmaceutical Research, 2019
View PDFchevron_right
Red cell sequestration during high dose intravenous immunoglobulin in idiopathic thrombocytopenic purpura
Elizabeth Macintyre
Blut, 1986
View PDFchevron_right
FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia
Gestur Vidarsson
Haematologica
View PDFchevron_right
All classes of murine IgG antibody mediate macrophage phagocytosis and lysis of erythrocytes
peter ralph
The Journal of Immunology
View PDFchevron_right
Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia
B. Chong
Blood, 1993
View PDFchevron_right
New monoclonal anti-human Fc gamma receptor II antibodies induce platelet aggregation
Koichi Iwata
Clinical & Experimental Immunology, 2008
View PDFchevron_right
Suppression of IL-4- and CD40-induced B-lymphocyte activation by intravenous immunoglobulin is not mediated through the inhibitory IgG receptor FcγRIIb
Sandra Bisotto
Journal of Allergy and Clinical Immunology, 2002
View PDFchevron_right